Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS)

CUSIP: 00461U105

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, $0.00001 par value
Shares outstanding
119,747,899
Total 13F shares
92,164,636
Share change
+5,343,089
Total reported value
$141,009,418
Put/Call ratio
90%
Price per share
$1.53
Number of holders
106
Value change
+$2,108,864
Number of buys
61
Number of sells
38

Quarterly Holders Quick Answers

What is CUSIP 00461U105?
CUSIP 00461U105 identifies ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS) as of Q1 2025

As of 31 Mar 2025, Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS) was held by 106 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 92,164,636 shares. The largest 10 holders included BML Capital Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Vivo Capital, LLC, Rock Springs Capital Management LP, VANGUARD GROUP INC, RA CAPITAL MANAGEMENT, L.P., MILLENNIUM MANAGEMENT LLC, Decheng Capital LLC, D. E. Shaw & Co., Inc., and MORGAN STANLEY. This page lists 106 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.